Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesThe new oral anticoagulants
Blood, 11/13/09
Garcia D et al. – These novel anticoagulant medications are being studied for the prevention and treatment of venous thromboembolism, the treatment of acute coronary syndromes and the prevention of stroke in patients with atrial fibrillation. This review will summarize published clinical trial data pertinent to apixaban, dabigatran and rivaroxaban.
Related Articles
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Relevance Score: 68%
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study
The Lancet Neurology, 10/16/09
Relevance Score: 66%
Pilot clinical study to evaluate the anticoagulant activity of fucoidan
Blood Coagulation & Fibrinolysis, 10/07/09
Relevance Score: 66%
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Relevance Score: 66%
Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarin
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 64%
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Development of a continuous assay for the measurement of tissue factor procoagulant activity on intact cells
Laboratory Investigation, 03/19/10
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients
Annals of Oncology, 03/17/10
Does donating blood for the first time during a national emergency create a better commitment to donating again
Vox Sanguinis, 03/16/10
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Anticancer effects of CAMEL peptide
Laboratory Investigation, 03/19/10
High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
British Journal of Haematology, 03/19/10
Article Search
Sponsor
Sponsor